Stay updated with breaking news from Gregory Piazza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This randomized trial compares the effect of intermediate-dose vs standard prophylactic enoxaparin on a composite outcome of acute venous thromboembolism (VTE),
Thrombolex, Inc., announced never-before-reported major reductions in obstruction in all of the segmental pulmonary arteries (PA), based on independent core...
PREVENT-HD is the largest randomized study to look at anticoagulation in nonhospitalized COVID-19 patients and joins a long list of smaller trials also showing no benefit with this approach.
A clinical decision-support tool designed to identify hospitalized patients in need of VTE prophylaxis cut the rate of thromboembolism at 30 days in the randomized IMPROVE-DD VTE trial.
Largest-yet RCT shows no benefit for non-hospitalized symptomatic patients despite elevated risk